NCT04330872 - An Investigation Into The Impact Of Enteric Coated Of Aspirin In Patients With Newly Diagnosed Ischemic Stroke. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 26, 2019

Primary Completion Date

January 4, 2020

Study Completion Date

March 4, 2020

Conditions

Stroke, Ischemic

Interventions

DRUG

Enteric Coated Aspirin Tablet

Study participants will be assigned to receive either EC Aspirin and will be required to continue taking them throughout the study (three days).

DRUG

Plain Aspirin

Study participants will be assigned to receive either Plain Aspirin and will be required to continue taking them throughout the study (three days).

Trial Locations (1)

Hamad Medical Corporation, Doha